• To understand the impact of Real-World Evidence in better understanding and managing neuroendocrine tumours.
  • To discuss how incorporating RWE can impact NETs patient experience.
  • To discuss the role of RWE in integrating novel treatments into clinical practice.

Chair IconChair

Dr. Winson Cheung

Speakers IconSpeakers

Dr. Jon Loree
Dr. Daniel Rayson

This program has been made possible through unrestricted support from Ipsen.